Recents Post

Gigasoft 2026 JavaScript Chart Comparison: ProEssentials, Highcharts, SciChart, LightningChart, ECharts

Gigasoft 2026 JavaScript Chart Comparison: ProEssentials, Highcharts, SciChart, LightningChart, ECharts

Back-to-School Health: Helping Children Start the School Year Strong with Accordia Health

Back-to-School Health: Helping Children Start the School Year Strong with Accordia Health

SBVA Appoints Two Global Investment Veterans as Venture Partners to Strengthen Portfolio Growth Support

SBVA Appoints Two Global Investment Veterans as Venture Partners to Strengthen Portfolio Growth Support

BABA ALERT: Alibaba Group Holding Limited (NYSE: BABA) Investors Urged to Contact Hagens Berman

BABA ALERT: Alibaba Group Holding Limited (NYSE: BABA) Investors Urged to Contact Hagens Berman

Ovintiv Announces Permian and Montney Inventory Additions

Ovintiv Announces Permian and Montney Inventory Additions

Tree Service in Spring Hill FL: Complete Care for Residential Properties

Tree Service in Spring Hill FL: Complete Care for Residential Properties

Symbos Receives Frost & Sullivan’s 2026 Australian Transformational Innovation Leadership Recognition for its Customer Experience Management Services

Symbos Receives Frost & Sullivan’s 2026 Australian Transformational Innovation Leadership Recognition for its Customer Experience Management Services

Caladan Goes Live on BitGo’s Go Network for Institutional Settlement

Caladan Goes Live on BitGo’s Go Network for Institutional Settlement

Back-to-school spending has become a stress test for household finances

Back-to-school spending has become a stress test for household finances

Egg Tuck to Bring Its Signature Soft-Scrambled Egg Sandwiches to San Diego’s Little Italy

Egg Tuck to Bring Its Signature Soft-Scrambled Egg Sandwiches to San Diego’s Little Italy

Business

AbbVie Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Topline results from Phase 3 EPCORE® DLBCL-4 trial evaluating epcoritamab in combination with lenalidomide demonstrated statistically significant and clinically meaningful improvement in progression-free survival (PFS) in patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL)EPCORE DLBCL-4…

Read the full release →

News provided by PR Newswire.